Category Archives: News

Inspiratory phase of the ventilator cycle

We studied 15 subjects with spinal cord injuries or neuromuscular diseases, who lived in extended-care facilities or at home. Thirteen subjects received ventilation with volume-controlled positive pressure and produced speech with the tracheostomy tube cuff deflated or with a cuffless … Continue reading

Posted in News | Leave a comment

Anti-Tissue Remodeling Effects of Corticosteroids

Tobacco is an important etiologic factor in the development of COPD, and is considered an aggravating factor in a number of interstitial lung diseases. In general, these pulmonary disorders are characterized by inflammation and the activation of tissue remodeling that … Continue reading

Posted in News, Pharmacy | Leave a comment

Risk Factors of ED

Diabetes The pathophysiology of ED in men with diabetes mellitus (DM) is complex and multifactorial. Men with DM, even those without significant comorbidities, suffer from a wide range of sexual dysfunction Viagra in Australia online, including decreased desire and sexual … Continue reading

Posted in Erectile Dysfunction, News | Leave a comment

Effects of testosterone o sexual function

It is commonly accepted that low serum testosterone may result in the combination of low sexual desire and erectile difficulties. In many patients, the correlation between sexual function  and serum testosterone values follows this logical pattern. Although this is a … Continue reading

Posted in Australia News, News | Tagged | Leave a comment

Medication for the healthy?

Modern Western culture does not restrict medication to the medically ill. Herbals, dietary supplements, and over-the-counter drugs, as well as highly publicized medications for sexual function such as Viagra (sildenafil) and Cialis (tadalafil), have blurred the categorical boundary between the … Continue reading

Posted in Erectile Dysfunction, News | Leave a comment

Pharmaceutical News: Spectrum signs ZEVALIN licensing deal with Bayer Adam Dempsey

Spectrum signs ZEVALIN licensing deal with Bayer Spectrum Pharmaceuticals has signed an agreement to acquire licensing rights to market ZEVALIN (ibritumomab tiuxetan) injection for intravenous use outside of the US from Bayer Healthcare. As per the agreement, Spectrum will have … Continue reading

Posted in News | Leave a comment

Pharmaceutical News: Watson Pharmaceuticals Incorporated (WPI) Shares Downgraded to “Neutral” by Citigroup (C) Analysts

Watson Pharmaceuticals Incorporated (WPI) Shares Downgraded to “Neutral” by Citigroup (C) Analysts Watson Pharmaceuticals Incorporated (NYSE: WPI) was downgraded by investment analysts at Citigroup (NYSE: C) from a “buy” rating to a “neutral” rating in a note issued to investors … Continue reading

Posted in News | Leave a comment

Pharmaceutical News: Cubist Pharmaceuticals (CBST) Posts Quarterly Results

Cubist Pharmaceuticals (CBST) Posts Quarterly Results Cubist Pharmaceuticals (CBST) posted its quarterly earnings results on Thursday. The company reported $0.11 earnings per share (EPS) for the quarter, missing the Thomson Reuters consensus estimate of $0.31 by $0.20. The company’s quarterly … Continue reading

Posted in News | Leave a comment

Pharmaceutical News: Pharmaceutical M&A in the Asia Pacific Region

Pharmaceutical M&A in the Asia Pacific Region Slowing growth continues in major developed markets, prompted by generic erosion of branded sales and increasing regulatory and cost containment pressures. Expansion into emerging Asia Pacific (APAC) markets is appealing not only because … Continue reading

Posted in News | Leave a comment

Pharmaceutical News: Swiss drug maker Novartis to cut almost 2,000 US jobs this year on patent expiry, failed trial

Swiss drug maker Novartis to cut almost 2,000 US jobs this year on patent expiry, failed trial Drug maker Novartis will cut 1,960 jobs in the United States this year in anticipation of lower sales for two of its hypertension … Continue reading

Posted in News | Leave a comment